Delivery Order SPE2DB20D2104-SPE2DB25FMPBP
- Not listed
- The Defense Logistics Agency awarded a $1,279.38 delivery order to AmerisourceBergen Drug Corp for Cryselle-28 tablets on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,741.91 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cryselle-28 tablets. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,782.19 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on October 17, 2025, with completion targeted for October 20, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,941.91 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Cryselle-28 tablets, a birth control medication, with a ceiling value of $5,708.05. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cryselle-28 tablets (a contraceptive medication) under a firm fixed-price contract structure. The award, valued at $1,643.68, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion prime vendor agreement running through December 2026. The delivery order carries no...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,702.12, is for the delivery of CRYSELLE-28 TABLET 28S medical supplies. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,556.30 firm fixed-price contract is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period ending on May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a ceiling value of $8,755.13 and a performance period ending on May 27, 2025. The contract is a firm fixed-price delivery order, indicating pre-set pricing. Amerisourcebergen Drug Corp is the prime contractor and...
- The Defense Logistics Agency awarded a $23,772.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, with an ultimate completion date of October 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the company's corporate...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMPBPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,221.73 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on April 22, 2025, with an ultimate completion date of April 23, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen Drug Corp provides critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and other healthcare supplies to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 4/22/25 |